Post-earnings recap
Reported
Thu, May 2, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Zimmer Biomet's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.92%. This could be due to the lack of revenue guidance, leaving investors uncertain about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.94 | N/A | +3.47% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting a commitment to long-term growth. However, they did not provide specific revenue guidance.
We are pleased with our EPS performance this quarter.
While we did not provide revenue guidance, we remain focused on our long-term strategies.